SIMS ANDREW JOHN HUGH MACINTYRE (Chief Financial Officer) purchased 71.7% of their position (4.10K shares) of PLUS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/11/2024ACC: 0000950170-24-105330
Officer· Chief Financial Officer
Since Feb 2020
+4.10K
Net shares
Net buyer
$5.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.10K
Price / share
$1.27
Trade value
$5.20K
% of position
71.7%
9/10/2024
5.72K→9.81K
Total
Net shares
+4.10K
Net value
$5.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2024 | P · Purchase | +4.10K | $1.27 | $5.20K | 71.7% | 5.72K | 9.81K |
| Total | +4.10K | $5.20K | ||||||
Derivative Transactions0
No derivative transactions reported